Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Urogen Pharma Ltd.

Clinical trials sponsored by Urogen Pharma Ltd., explained in plain language.

UroGen Pharma Ltd. URGN NASDAQ

Develops therapies for urological cancers and diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New bladder cancer drug shows early promise in small trial

Disease control Completed

This early-phase trial tested a new drug called UGN-301 (zalifrelimab) given directly into the bladder for people with recurrent non-muscle invasive bladder cancer. The study included 51 participants and aimed to check safety and find the right dose, both alone and with other dru…

Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC